Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

I am confident that Gottlieb, who always was

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
moosedogger Member Profile
 
Followed By 4
Posts 935
Boards Moderated 0
Alias Born 07/18/06
160x600 placeholder
Aurinia Pharmaceuticals gains amid takeover speculation Seeking Alpha - 12/2/2021 11:06:41 AM
Aurinia falls 28% amid mixed shelf offering, skepticism on buyout rumors Seeking Alpha - 11/22/2021 12:43:00 PM
Aurinia Pharmaceuticals drops 12% after filing mixed shelf offering Seeking Alpha - 11/19/2021 5:26:12 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 11/19/2021 5:05:35 PM
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference Business Wire - 11/10/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/3/2021 4:21:48 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/3/2021 4:14:03 PM
Aurinia Pharma slips as uptake of lupus nephritis therapy slows Seeking Alpha - 11/3/2021 8:28:18 AM
Aurinia Pharma EPS misses by $0.06, beats on revenue Seeking Alpha - 11/3/2021 6:11:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/3/2021 6:02:00 AM
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates Business Wire - 11/3/2021 6:00:00 AM
Aurinia Pharma Q3 2021 Earnings Preview Seeking Alpha - 11/2/2021 11:59:17 AM
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis Business Wire - 11/1/2021 10:12:00 AM
Aurinia Pharma drops after GlaxoSmithKline denies report on potential bid Seeking Alpha - 11/1/2021 10:01:23 AM
Aurinia Pharma may be worth $45-$53/share in a potential sale - analyst Seeking Alpha - 10/29/2021 10:14:43 AM
Aurinia Pharmaceuticals gains on speculation of other potential bidder interest Seeking Alpha - 10/28/2021 10:19:31 AM
Oppenheimer cuts Aurinia to perform on M&A chatter, recent share price rise Seeking Alpha - 10/28/2021 9:26:15 AM
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021 Business Wire - 10/27/2021 7:07:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/26/2021 4:34:01 PM
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021 Business Wire - 10/26/2021 4:10:00 PM
Aurinia Pharmaceuticals Shares Rally on Report of Bristol Myers Interest Dow Jones News - 10/25/2021 9:25:00 AM
EDIT, AUPH and DWAC among after hours Seeking Alpha - 10/22/2021 5:21:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/22/2021 4:31:38 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/17/2021 4:04:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2021 5:02:32 PM
moosedogger   Monday, 01/11/21 08:19:15 AM
Re: Zeppo post# 11657
Post # of 14434 
I am confident that Gottlieb, who always was a proponent of on-time evaluations and fast-tracks, where warranted, is familiar with AUPH and its test results.

It would be very surprising if he's not. He's part of the team at NEA Managment, which includes AUPH among it's 54 largest positions with over 5M shares.

He also worked for GSK at one time so he's probably more than familiar with LN.

https://fintel.io/so/us/auph

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences